AcademyHealth recognizes McGlynn with Distinguished Investigator Award

Thursday, June 28, 2012 12:18 PM

AcademyHealth, a national organization serving the fields of health services, policy research and professionals, has named Elizabeth McGlynn, Ph.D., as the 2012 recipient of its Distinguished Investigator Award.

A high honor in the field of health services research and health policy, the Distinguished Investigator Award recognizes individuals who have made significant and lasting contributions to the field of health services research through scholarship and teaching, advancement of science and methods and leadership.

McGlynn is the director of the Kaiser Permanente Center for Effectiveness & Safety Research, an internationally-known expert in the evaluation of health care quality and a leader in the field of health services research.

"Dr. McGlynn has dedicated her career to helping us understand, measure and evaluate health care quality," said Dr. Lisa Simpson, president and CEO of AcademyHealth. "Her research, leadership and counsel have been critically important to our ability to identify evidence-based strategies to improve care quality and outcomes. She is truly deserving of this high honor from our field."

Among McGlynn’s many contributions to the understanding of the level and appropriateness of U.S. health care is the landmark 2003 study "The Quality of Health Care Delivered to Adults in the United States," which found that, on average, American adults receive about half of recommended care. The study used a new method for evaluating quality that was developed under McGlynn's leadership and garnered significant media attention that contributed to a much broader understanding of the size and nature of the quality problem in the U.S. The research was recognized as the 2004 AcademyHealth Article-of-the-Year.

McGlynn is currently leading efforts to further leverage Kaiser Permanente's research infrastructure and integrated health care system to study the effectiveness and safety of new drugs, devices and therapeutic practices.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 22

Roche/Genentech plans pilot trial to measure patientpreference for participating at home v. at study site

Bipartisan 21st Century Cures initiative prepares to draft legislation to accelerate biomedical R&D, lower cost

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs